Please Wait
Applying Filters...
menu
    • menu
    Fermion-PSE
    News
    Fermion - leader in sustainable API manufacturing

    29 Oct 2024

    // PRESS RELEASE

    Green chemistry at Fermion

    20 Aug 2024

    // PRESS RELEASE

    Fermion has completed first investment for new Mfg capacity for APIs

    12 Mar 2024

    // PRFESS RELEASE

    Data Compilation
    #PharmaFlow

    Fermion VB

    Contact Supplier

    Website

    CPHI Middle east

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/yx_EZVMs2Hw
    Menu

    Fermion Oy

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 14-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol

    02 29,10-Dehydro Folitixorin Chloride

    03 1N-(2-hydroxy-5-((RS)-1-hydroxy-2-(((RS)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide

    04 1N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

    05 1N-benzyl-6-(4-phenyl-butoxy)hexan-1-amine hydrochloride

    06 1methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

    07 1methyl 2-amino-3-hydroxypropanoate hydrochloride

    08 1±2-amino-3-hydroxypropanehydrazide hydrochloride

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxy...

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    89365-50-4
    Salmeterol Xinafoate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    01

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol

    Finland
    CPHI Middle east
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxy...

    CAS Number : 89365-50-4

    End Use API : Salmeterol Xinafoate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    9,10-Dehydro Folitixorin Chloride

    Intermediate Web Link

    Market Place

    804563-04-0
    Levoleucovorin Calcium
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    02

    9,10-Dehydro Folitixorin Chloride

    Finland
    CPHI Middle east
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    9,10-Dehydro Folitixorin Chloride

    CAS Number : 804563-04-0

    End Use API : Levoleucovorin Calcium

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    9,10-Dehydro Folitixorin Chloride

    Intermediate Web Link

    Market Place

    804563-04-0
    Calcium Folinate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion

    03

    9,10-Dehydro Folitixorin Chloride

    Finland
    CPHI Middle east
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.

    Fermion Oy

    9,10-Dehydro Folitixorin Chloride

    CAS Number : 804563-04-0

    End Use API : Calcium Folinate

    About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a f...

    fermion

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWith Fermion, start the journey of your innovative API.
    Contact Supplier Contact Supplier
    Flag Finland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    methyl 1-acetyl-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-c...

    Intermediate Web Link

    Market Place

    1168152-07-5
    Nintedanib Esylate
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together w...
    Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
    fermion